• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Conformational modulation of influenza virus hemagglutinin: characterization and in vivo efficacy of monomeric form

tetano

Editor, Senior Moderator
Sci Rep. 2017 Aug 8;7(1):7540. doi: 10.1038/s41598-017-08021-x.
[h=1]Conformational modulation of influenza virus hemagglutinin: characterization and in vivo efficacy of monomeric form.[/h] Seok JH[SUP]1[/SUP], Kim J[SUP]2[/SUP], Lee DB[SUP]1[/SUP], Cho KJ[SUP]3[/SUP], Lee JH[SUP]1[/SUP], Bae G[SUP]2[/SUP], Chung MS[SUP]2[/SUP], Kim KH[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Mutational changes that mostly occur at the head region of hemagglutinin (HA) lead to the emergence of new epidemic influenza viruses, whereas HA antigens have been modified to generate broadly neutralizing antibodies toward highly conserved epitopes in the HA stem. Interestingly, a recent analysis of serum antibody repertoires showed that broadly neutralizing antibodies bind to HA monomer at a conserved region occluded at the intermonomer interface of HA trimer and confer protection in animal models. We showed previously that the recombinant HA ectodomain from a pandemic strain A/Korea/01/2009 was monomeric in solution and crystal structure. In order to examine the potential antigenicity of a monomeric form, we designed HA monomer that incorporates mutations to destabilize trimer conformations. Starting with the HA trimer from a seasonal strain A/Thailand/CU44/2006, mutations were introduced at the intermonomer interface, Ser199 of HA1 and Gly47, Arg75, Phe88, Val91, and Arg106 of HA2. Two mutants, F88E and V91W, were characterized to form a monomer and their double mutant F88E/V91W monomer was selected as an antigen. Animal studies showed that the HA monomer induced protective immunity in vivo, comparable to the trimer, albeit low antibody titers in sera.


PMID: 28790432 PMCID: PMC5548806 DOI: 10.1038/s41598-017-08021-x
Free PMC Article
 
Back
Top Bottom